Great Point Partners’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Great Point Partners’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-31,250	Closed	-$395K	–	43
2014 Q4	$395K	Sell	31,250 -147,650	-83%	-$2.14M	0.19%	27
2014 Q3	$2.75M	Sell	178,900 -8,600	-5%	-$181K	1.18%	27
2014 Q2	$5.08M	Buy	187,500 +16,345	+10%	+$403K	2.26%	16
2014 Q1	$4.59M	Buy	+171,155	New	+$4.35M	2.4%	16

Other funds holding ANTH

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Great Point Partners's ANTH Position: Q1 2015 in Review

Great Point Partners sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2015, closing a stake of 31,250 shares — an estimated $395K sold.

Great Point Partners first reported a position in ANTH in Q1 2014 and held it in 4 quarters. The position peaked at $5.08M in Q2 2014. 43 funds tracked by Wall St. Rank hold ANTH as of Q1 2015.

Great Point Partners reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
Great Point Partners sold 31,250 Anthera Pharmaceuticals, Inc. shares in Q1 2015, an estimated $395K.
Great Point Partners first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2014 and held it in 4 quarters.
Great Point Partners's Anthera Pharmaceuticals, Inc. position peaked at $5.08M in Q2 2014.
43 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2015.

Based on Great Point Partners's 13F filing for Q1 2015, filed 15 May 2015.